These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8107522)

  • 21. Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin.
    Lad PM; Olson CV; Smiley PA
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):869-73. PubMed ID: 2983319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
    Bonora GM; Toniolo C; Freer RJ; Becker EL
    Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of neutrophil superoxide production by fanetizole.
    Styrt B; Rocklin RE; Klempner MS
    Inflammation; 1985 Sep; 9(3):233-44. PubMed ID: 2995253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.
    Zimmerli W; Seligmann B; Gallin JI
    J Clin Invest; 1986 Mar; 77(3):925-33. PubMed ID: 3005369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
    Lavigne MC; Murphy PM; Leto TL; Gao JL
    Cell Immunol; 2002; 218(1-2):7-12. PubMed ID: 12470609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction.
    Lohr KM; Feix JB; Kurth C
    J Infect Dis; 1984 Nov; 150(5):643-52. PubMed ID: 6092486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors.
    Dalpiaz A; Scatturin A; Vertuani G; Pecoraro R; Borea PA; Varani K; Traniello S; Spisani S
    Eur J Pharmacol; 2001 Jan; 411(3):327-33. PubMed ID: 11164392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant protein A differentially regulates peripheral and inflammatory neutrophil chemotaxis.
    Schagat TL; Wofford JA; Greene KE; Wright JR
    Am J Physiol Lung Cell Mol Physiol; 2003 Jan; 284(1):L140-7. PubMed ID: 12388367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postbinge effects of acute alcohol intoxication on hepatic free radical formation.
    Bautista AP; Spitzer JJ
    Alcohol Clin Exp Res; 1996 May; 20(3):502-9. PubMed ID: 8727245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of FMLP receptors on rat macrophages.
    Walker BA; Seiler AJ; Owens CA; Hagenlocker BE; Ward PA
    J Leukoc Biol; 1991 Dec; 50(6):600-6. PubMed ID: 1658174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH.
    Dugas H; Laroche M; Ptak M; Labbé H
    Int J Pept Protein Res; 1993 Jun; 41(6):595-605. PubMed ID: 8394292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational aspects of human formylpeptide receptor antagonists.
    Scatturin A; Vertuani G; Pecoraro R; Dalpiaz A; Boggian M; Ferretti ME; Spisani S
    Arzneimittelforschung; 1999 Oct; 49(10):873-7. PubMed ID: 10554666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
    Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Kupffer cells in the ethanol-induced oxidative stress in the liver.
    Bautista AP; Spitzer JJ
    Front Biosci; 1999 Jul; 4():D589-95. PubMed ID: 10417056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
    Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
    J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the synthetic inhibitor tosylamino-phenylethyl-chloromethylketone on chemotactic peptide receptor activation and superoxide production in human neutrophils.
    Suter S; Lew PD; Waldvogel FA
    Pediatr Res; 1986 Sep; 20(9):848-52. PubMed ID: 3018658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects.
    Dalpiaz A; Ferretti ME; Pecoraro R; Fabbri E; Traniello S; Scatturin A; Spisani S
    Biochim Biophys Acta; 1999 Jun; 1432(1):27-39. PubMed ID: 10366725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.